| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/11/1997 | EP0777484A1 Intravenous alendronate formulations |
| 06/11/1997 | EP0777482A1 Combined preparation for the therapy of immune diseases |
| 06/11/1997 | EP0777481A1 Use of n-substituted phenothiazines |
| 06/11/1997 | EP0777473A1 Compositions and methods for the control of smoking |
| 06/11/1997 | EP0711141B1 Cosmetic or pharmaceutical and particularly dermatological composition containing an extract of tephrosia, particularly tephrosia purpurea |
| 06/11/1997 | EP0656786A4 Health supplements containing phyto-oestrogens, analogues or metabolites thereof. |
| 06/11/1997 | EP0557305B1 (2-thienyl) alkylamine derivatives having neuroprotective properties |
| 06/11/1997 | CN1151758A Novel growth of differentiation factor of the TGF- 'beta' family |
| 06/11/1997 | CN1151736A Di-oxadiazole derivatives as antihyperglycemic agents |
| 06/11/1997 | CN1151405A Propiophenone derivative and processes for preparing the same |
| 06/11/1997 | CN1151401A Use of intermediates for production of aromatic aminoalcohol derivatives having anti-diabetic and anti-obesity properties |
| 06/11/1997 | CN1151399A Novel hydroxylpyridinones |
| 06/11/1997 | CN1151288A Nutrient for prevention and treatment of fatty liver caused by drinking wine and fat and its mfg. method |
| 06/10/1997 | US5637771 Compound useful for lowering cholesterol |
| 06/10/1997 | US5637742 Wound healing agents, skin disorders, cosmetics |
| 06/10/1997 | US5637610 Composition containing dioxabicyclo [3.3.0] octane derivative |
| 06/10/1997 | US5637598 Methods of inhibiting bone loss |
| 06/10/1997 | US5637577 Treatment of potozoal diseases |
| 06/10/1997 | US5637567 Method for modifying, diagnosing, and screening for IGF-I sensitive cell barrier properties |
| 06/10/1997 | US5637318 Increased oxygen penetration of skin |
| 06/10/1997 | US5637316 Deep penetration of skin |
| 06/10/1997 | CA2059510C Use of nadh and nadph as energy substitutes |
| 06/09/1997 | CA2190708A1 Aminoalkyl substituted benzo-heterocyclic compounds |
| 06/09/1997 | CA2190699A1 Tertiary amines |
| 06/05/1997 | WO1997019918A1 Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof |
| 06/05/1997 | WO1997019914A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds |
| 06/05/1997 | WO1997019683A1 Hydrolysis-optimized lipid emulsions and use thereof |
| 06/05/1997 | DE19648566A1 Isotonic lipid emulsion for parenteral application for nourishment, |
| 06/05/1997 | DE19544686A1 Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Amino acid derivatives, medicaments containing these compounds and processes for their preparation |
| 06/04/1997 | EP0776899A1 Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 06/04/1997 | EP0776895A1 Protein kinase C inhibitor |
| 06/04/1997 | EP0776339A1 Mhc complexes and uses thereof |
| 06/04/1997 | EP0776325A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 06/04/1997 | EP0776323A1 Salts of an anti-migraine indole derivative |
| 06/04/1997 | EP0672119A4 Retroviral mediated transfer of the human multiple drug resistance gene. |
| 06/04/1997 | EP0527802B1 Ligand for the neu gene product |
| 06/04/1997 | CN1150947A Alkenyl-benzoyl guanidine derivant |
| 06/03/1997 | US5635536 Emulsion suitable for administering a sphingolipid |
| 06/03/1997 | US5635534 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses |
| 06/03/1997 | US5635529 Sulfonamidodioxepanes, methods of preparation, intermediates, salts and use thereof |
| 06/03/1997 | US5635512 Method for modifying or resetting the prolactin rhythm of an insulin insensitive or diabetic animal or human |
| 06/03/1997 | US5635503 Dihydropyridine npy antagonists: piperazine derivatives |
| 06/03/1997 | US5635374 Bone calcification factor and recombinant production of the factor nucleic acid encoding |
| 06/03/1997 | US5635189 Tocopherols |
| 06/03/1997 | CA2098199C Psyllium and cholestyramine compositions with improved palatability |
| 05/29/1997 | WO1997019177A1 SYNTHETIC MAMMALIAN α-N-ACETYLGLUCOSAMINIDASE AND GENETIC SEQUENCES ENCODING SAME |
| 05/29/1997 | WO1997019104A1 Cyclopeptolides |
| 05/29/1997 | WO1997019080A1 Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018833A1 Methods of increasing lean tissue mass using ob protein compositions |
| 05/29/1997 | WO1997018829A1 Cartilage/bone inducing materials for reparation |
| 05/29/1997 | WO1997018809A1 Protein kinase c inhibitor |
| 05/29/1997 | WO1997018808A1 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus |
| 05/29/1997 | WO1997013505A3 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 05/29/1997 | WO1997013500A3 LIPOSOME FORMULATIONS OF 5β STEROIDS |
| 05/29/1997 | CA2358862A1 Methods of increasing lean tissue mass using ob protein compositions |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | CA2236163A1 Methods of increasing lean tissue mass using ob protein compositions |
| 05/28/1997 | EP0775202A1 Human interleukin variants generated by alternative splicing |
| 05/28/1997 | EP0775126A1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 05/28/1997 | EP0775118A1 Benzimidazole derivatives having dopaminergic activity |
| 05/28/1997 | EP0775103A1 Retinoic acid x-receptor ligands |
| 05/28/1997 | EP0667850B1 Tartronic acids, their acetalic ethers and o-esters |
| 05/28/1997 | EP0652884B1 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity |
| 05/28/1997 | CN1150803A Pyrazolo and pyrrolopyridines |
| 05/28/1997 | CN1150799A Benzoheterocyclic derivatives |
| 05/28/1997 | CN1150798A 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption |
| 05/28/1997 | CN1150760A Methods for inducing T cell tolerance to tissue or organ graft |
| 05/27/1997 | US5633287 N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| 05/27/1997 | US5633276 Melatonin system disorders |
| 05/27/1997 | US5633270 Thiazolidine derivatives, preparation thereof and drugs containing samem |
| 05/27/1997 | US5633246 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 05/27/1997 | US5633014 Solid, non-porous microspheres of injectable analgesic and adjuvant that decreases the melting point of the analgesic obtained by spraying mixture in melted state to form droplets and rapidly freezing droplets |
| 05/22/1997 | WO1997018320A1 Process for the preparation of materials with a high content of long chain polyunsaturated fatty acids |
| 05/22/1997 | WO1997018304A1 Methods for modulation of cholesterol transport |
| 05/22/1997 | WO1997018303A1 Rac-proteine kinase as therapeutic agent or in diagnostics |
| 05/22/1997 | WO1997018237A1 Chemokine from niddm pancreas |
| 05/22/1997 | WO1997018223A1 Improved method and agents for inhibiting protein aging |
| 05/22/1997 | WO1997017994A1 Treatment of diabetes with a glucokinase gene |
| 05/22/1997 | WO1997017992A1 Improved formulation for administration of steroid compounds |
| 05/22/1997 | WO1997017969A1 Dihydropyrimidines and uses thereof |
| 05/22/1997 | WO1997002004A3 Methods for treating diabetes |
| 05/22/1997 | CA2240192A1 Methods for screening compounds that modulate cholesterol transport |
| 05/22/1997 | CA2237998A1 Chemokine from niddm pancreas |
| 05/22/1997 | CA2237774A1 Dihydropyrimidines and uses thereof |
| 05/22/1997 | CA2237565A1 Improved method and agents for inhibiting protein aging |
| 05/22/1997 | CA2236332A1 Treatment of diabetes with a glucokinase gene |
| 05/21/1997 | EP0774459A1 Sulfonylamino-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent as well as medicament containing them |
| 05/21/1997 | EP0774458A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent |
| 05/21/1997 | EP0774457A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent |
| 05/21/1997 | EP0774259A1 New use of organic compounds |
| 05/21/1997 | EP0773942A1 4-indole derivatives as serotonin agonists and antagonists |
| 05/21/1997 | EP0773790A1 Invariant chain compositions useful for treating autoimmune diseases |
| 05/21/1997 | EP0674509A4 Methods for treatment with dimercaptosuccinic acid (dmsa). |
| 05/21/1997 | CN1150435A Process for removing bile salt from patient and alkylated compositions therefor |
| 05/21/1997 | CN1150433A Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 05/21/1997 | CN1150428A Corticotropin releasing factor antagonists |
| 05/21/1997 | CN1150155A Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 05/21/1997 | CN1150036A 一种治疗“下消”型糖尿病的糖脂克药物组合物 Glycolipids g pharmaceutical composition treating "next elimination" diabetes mellitus |
| 05/21/1997 | CN1150035A 一种治疗“上消”型糖尿病的糖脂克药物组合物 G glycolipid pharmaceutical composition of treating "the consumer" diabetes mellitus |